Feasibility of Extracted-Overlay Fusion Imaging for Intraoperative Treatment Evaluation of Radiofrequency Ablation for Hepatocellular Carcinoma

Background and Aims: Extracted-overlay fusion imaging is a novel computed tomography/magnetic resonance-ultrasonography (CT/MR-US) imaging technique in which a target tumor with a virtual ablative margin is extracted from CT/MR volume data and synchronously overlaid on US images. We investigated the applicability of the technique to intraoperative evaluation of radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC). Methods: This retrospective study analyzed 85 HCCs treated with RFA using extracted-overlay fusion imaging for guidance and evaluation. To perform RFA, an electrode was inserted targeting the tumor and a virtual 5-mm ablative margin overlaid on the US image. Following ablation, contrast-enhanced US (CEUS) was performed to assess the ablative margin, and the minimal ablative margins were categorized into three groups: (I) margin <0 mm (protrusion), (II) margin 0 to <5 mm, and (III) margin ≥5 mm. Margin assessment was based on the positional relationship between the overlaid tumor plus margin and the perfusion defect of the ablation zone. Tumors in group I underwent repeat ablation until they were in groups II or III. The final classifications were compared with those obtained by retrospectively created fusion images of pre- and post-RFA CT or MR imaging (CT-CT/MR-MR fusion imaging). Results: Treatment evaluation was impossible using CEUS in six HCCs because the tumors were located far below the body surface. Of the remaining 79 HCCs, the categorizations of minimal ablative margins between CEUS extracted-overlay fusion imaging and CT-CT/MR-MR fusion imaging were in agreement for 72 tumors (91.1%) (Cohen's quadratic-weighted kappa coefficient 0.66, good agreement, p<0.01). Conclusions: Extracted-overlay fusion imaging combined with CEUS is feasible for the evaluation of RFA and enables intraoperative treatment evaluation without the need to perform contrast-enhanced CT.

[1]  K. Imanaka,et al.  Three-dimensional registration of images obtained before and after radiofrequency ablation of hepatocellular carcinoma to assess treatment adequacy. , 2014, AJR. American journal of roentgenology.

[2]  T. Murakami,et al.  Comparative evaluation of three-dimensional Gd-EOB-DTPA-enhanced MR fusion imaging with CT fusion imaging in the assessment of treatment effect of radiofrequency ablation of hepatocellular carcinoma , 2014, Abdominal Imaging.

[3]  T. Murakami,et al.  Usefulness of the Extracted-Overlay Function in CT/MR-Ultrasonography Fusion Imaging for Radiofrequency Ablation of Hepatocellular Carcinoma , 2013, Digestive Diseases.

[4]  T. Murakami,et al.  Utility of computed tomography fusion imaging for the evaluation of the ablative margin of radiofrequency ablation for hepatocellular carcinoma and the correlation to local tumor progression , 2013, Hepatology research : the official journal of the Japan Society of Hepatology.

[5]  Y. Kodama,et al.  Feasibility of fused imaging for the evaluation of radiofrequency ablative margin for hepatocellular carcinoma , 2013, Hepatology research : the official journal of the Japan Society of Hepatology.

[6]  Takamichi Murakami,et al.  Ultrasonography Fusion Imaging System Increases the Chance of Radiofrequency Ablation for Hepatocellular Carcinoma with Poor Conspicuity on Conventional Ultrasonography , 2013, Oncology.

[7]  Kinuyo Hatanaka,et al.  Usefulness of Contrast-Enhanced Ultrasonography to Evaluate the Post-Treatment Responses of Radiofrequency Ablation for Hepatocellular Carcinoma: Comparison with Dynamic CT , 2013, Oncology.

[8]  Luca Mainardi,et al.  Radiofrequency ablation of liver tumors: quantitative assessment of tumor coverage through CT image processing , 2013, BMC Medical Imaging.

[9]  P. Grenier,et al.  Contrast-enhanced ultrasound (CEUS) follow-up after radiofrequency ablation or cryoablation of focal liver lesions: treated-area patterns and their changes over time , 2013, European Radiology.

[10]  Jun Kato,et al.  Ablative margin states by magnetic resonance imaging with ferucarbotran in radiofrequency ablation for hepatocellular carcinoma can predict local tumor progression , 2013, Journal of Gastroenterology.

[11]  Takamichi Murakami,et al.  Usefulness of the Multimodality Fusion Imaging for the Diagnosis and Treatment of Hepatocellular Carcinoma , 2012, Digestive Diseases.

[12]  Young Jun Kim,et al.  Percutaneous radiofrequency ablation of hepatocellular carcinoma: fusion imaging guidance for management of lesions with poor conspicuity at conventional sonography. , 2012, AJR. American journal of roentgenology.

[13]  Masahiro Okada,et al.  Efficacy of fusion imaging combining sonography and hepatobiliary phase MRI with Gd-EOB-DTPA to detect small hepatocellular carcinoma. , 2012, AJR. American journal of roentgenology.

[14]  M. Okada,et al.  Use of fusion imaging combining contrast-enhanced ultrasonography with a perflubutane-based contrast agent and contrast-enhanced computed tomography for the evaluation of percutaneous radiofrequency ablation of hypervascular hepatocellular carcinoma. , 2012, European journal of radiology.

[15]  Jun Kato,et al.  Assessment of ablative margin by unenhanced magnetic resonance imaging after radiofrequency ablation for hepatocellular carcinoma. , 2012, European journal of radiology.

[16]  E. Jung,et al.  Volume Navigation with Contrast Enhanced Ultrasound and Image Fusion for Percutaneous Interventions: First Results , 2012, PloS one.

[17]  S. Kumano,et al.  Hypervascular hepatocellular carcinomas: detection with gadoxetate disodium-enhanced MR imaging and multiphasic multidetector CT , 2012, European Radiology.

[18]  Y. Osaki,et al.  Percutaneous radiofrequency ablation therapy for hepatocellular carcinoma: a proposed new grading system for the ablative margin and prediction of local tumor progression and its validation , 2011, Journal of Gastroenterology.

[19]  Ernst Klotz,et al.  Safety margin assessment after radiofrequency ablation of the liver using registration of preprocedure and postprocedure CT images. , 2011, AJR. American journal of roentgenology.

[20]  Sheng Xu,et al.  Clinical utility of real-time fusion guidance for biopsy and ablation. , 2011, Journal of vascular and interventional radiology : JVIR.

[21]  Sumio Watanabe,et al.  Radiofrequency ablation of hepatocellular carcinoma: The feasibility of magnetic resonance imaging with gadolinium ethoxybenzyl diethylene triamine pentaacetic acid for evaluating the ablative margin , 2010, Hepatology research : the official journal of the Japan Society of Hepatology.

[22]  Won Jae Lee,et al.  The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion. , 2010, AJR. American journal of roentgenology.

[23]  Ankur Kapoor,et al.  Navigation systems for ablation. , 2010, Journal of vascular and interventional radiology : JVIR.

[24]  A. Kunimatsu,et al.  Radiofrequency ablation of the liver: determination of ablative margin at MR imaging with impaired clearance of ferucarbotran--feasibility study. , 2009, Radiology.

[25]  Katsunori Saigenji,et al.  Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin. , 2007, AJR. American journal of roentgenology.

[26]  H. Ueno,et al.  Satellite lesions in patients with small hepatocellular carcinoma with reference to clinicopathologic features , 2002, Cancer.